ArticleCancer research2019

Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic Cancer.

Tara N Fujimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.